NCT01815567

Brief Summary

The purpose of this study is to study the impact of blood pressure on cognitive performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
234

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2012

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 21, 2013

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2020

Completed
Last Updated

May 7, 2021

Status Verified

May 1, 2021

Enrollment Period

7.7 years

First QC Date

September 20, 2012

Last Update Submit

May 5, 2021

Conditions

Keywords

HypertensionRetinal DisorderCognitive impairment

Outcome Measures

Primary Outcomes (1)

  • DETECT neurocognitive outcome scores (Z-scores) in association with blood pressure measures and retinal pathology (isolated retinal hemorrhage, grade III/IV hemorrhagic retinopathy)

    We aim to determine the correlation (if any) between the severity of blood pressure and DETECT neurocognitive outcomes as well as the correlation (if any) between known Hypertensive retinal disease and DETECT neurocognitive outcomes. Appropriate statistical analysis will be performed to compare clinical retinal findings, BP values, and DETECT neurocognitive test outcomes. Subject level data will only be collected on the day of Emergency Department presentation. Subjects will not be followed after their initial enrollment. The study duration is projected for 12 months

    12 months

Secondary Outcomes (1)

  • Variance of DETECT scores (Z-score) attributed to reading level

    One year study periord (12 months)

Study Arms (4)

controlled hypertension

hypertension with medication controlled

uncontrolled hypertension

non-controlled hypertension

hypertensive urgency

hypertensive urgency no previous history or antihypertensives

asymptomatic normotensive

asymptomatic normotensive control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Emergency department patients that meet the inclusion/exclusion criteria.

You may qualify if:

  • Patients triaged to the Grady Memorial Hospital Emergency Department or Marcus Trauma Unit
  • Age \>18 and \<65
  • Documented history of hypertension plus one or more of the following:
  • current antihypertensive use with controlled blood pressure
  • elevated Emergency Department systolic blood pressure or diastolic blood pressure
  • OR -
  • Acutely elevated Emergency Department systolic blood pressure or diastolic blood pressure on 2 separate Emergency Department measurements in the absence of a history of hypertension
  • OR -
  • Normal systolic blood pressure or diastolic blood pressure in the absence of hypertension.

You may not qualify if:

  • Non-English speaking
  • Pre-visit cognitive impairment
  • Physical or psychological impairments that would prohibit comprehension and completion of DETECT testing
  • Inability to obtain adequate fundoscopic photos
  • Acute intoxication, altered mental status, or head injury within the last 6 months
  • Opiate or benzodiazepine administration by treating providers
  • Clinical condition not allowing testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Grady Memorial Hospital

Atlanta, Georgia, 30303, United States

Location

MeSH Terms

Conditions

HypertensionRetinal DiseasesCognitive Dysfunction

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesEye DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Tamara Espinoza, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 20, 2012

First Posted

March 21, 2013

Study Start

November 1, 2012

Primary Completion

July 15, 2020

Study Completion

July 15, 2020

Last Updated

May 7, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations